Aptose Biosciences Inc. Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q2 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Aptose Biosciences Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q2 2017 to Q4 2024.
  • Aptose Biosciences Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending December 31, 2024 was $0.000, a 100% decline year-over-year.
  • Aptose Biosciences Inc. Net Cash Provided by (Used in) Investing Activities for the twelve months ending December 31, 2024 was $18K, a 99.8% decline year-over-year.
  • Aptose Biosciences Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $18K, a 99.8% decline from 2023.
  • Aptose Biosciences Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $9.96M, a 66.9% decline from 2022.
  • Aptose Biosciences Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $30.1M.
Net Cash Provided by (Used in) Investing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $18K $0 -$1.93M -100% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 $1.95M $0 -$13M -100% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $14.9M $2.01M +$3.97M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $10.9M -$1.99M +$969K +32.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $9.96M $1.93M -$15.6M -89% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 $25.6M $13M +$18M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $7.58M -$1.96M -$12M -119% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $19.6M -$2.96M -$10.5M -139% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $30.1M $17.6M +$37.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$7.52M -$5.08M -$4.89M -2645% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$2.62M $10.1M +$5.07M +101% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$7.69M $7.51M +$27.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$35.2M -$20M -$48M -172% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $12.8M -$185K +$4.21M +95.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $8.56M $5M +$3.52M +238% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $5.04M -$20M -$7.59M -61% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $12.6M $28M +$36.3M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$23.6M -$4.4M -$3.36M -322% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$20.3M $1.48M +$9.51M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$29.8M -$12.4M -$12.4M -51679% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$17.4M -$8.28M -$8.19M -9526% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 -$9.18M -$1.04M -$1.01M -3621% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$8.16M -$8.03M -$8.18M -5451% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $12K -$24K $0 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $12K -$86K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$28K -$19K -211% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $150K +$3.14M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$24K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q3 2017 -$9K Jul 1, 2017 Sep 30, 2017 8-K 2019-03-12
Q2 2017 -$2.99M Apr 1, 2017 Jun 30, 2017 8-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.